Literatures

Primary Site >> Colorectal Cancer

Gene >> TXN

1.
Journal:	Biochim Biophys Acta. 1994 Aug 2;1218(3):292-6.
Title:	The predicted amino acid sequence of human thioredoxin is identical to that of the autocrine growth factor human adult T-cell derived factor (ADF): thioredoxin mRNA is elevated in some human tumors.
Author:	Gasdaska, P Y\|Oblong, J E\|Cotgreave, I A\|Powis, G
PMID:	8049254

2.
Journal:	Clin Cancer Res. 1996 Feb;2(2):427-32.
Title:	Increased expression of thioredoxin/adult T-cell leukemia-derived factor in cisplatin-resistant human cancer cell lines.
Author:	Yamada, M\|Tomida, A\|Yoshikawa, H\|Taketani, Y\|Tsuruo, T
PMID:	9816187

3.
Journal:	Cancer Res. 1997 Nov 1;57(21):4965-70.
Title:	Mechanisms of the regulation of thioredoxin reductase activity in cancer cells by the chemopreventive agent selenium.
Author:	Gallegos, A\|Berggren, M\|Gasdaska, J R\|Powis, G
PMID:	9354464

4.
Journal:	Cancer Chemother Pharmacol. 1997;40(1):31-7.
Title:	Overexpression of thioredoxin does not confer resistance to cisplatin in transfected human ovarian and colon cancer cell lines.
Author:	Yamada, M\|Tomida, A\|Yoshikawa, H\|Taketani, Y\|Tsuruo, T
PMID:	9137526

5.
Journal:	Hum Pathol. 2000 Apr;31(4):475-81.
Title:	Thioredoxin, a putative oncogene product, is overexpressed in gastric carcinoma and associated with increased proliferation and increased cell survival.
Author:	Grogan, T M\|Fenoglio-Prieser, C\|Zeheb, R\|Bellamy, W\|Frutiger, Y\|Vela, E\|Stemmerman, G\|Macdonald, J\|Richter, L\|Gallegos, A\|Powis, G
PMID:	10821495

6.
Journal:	Oncol Rep. 2002 Jan-Feb;9(1):75-9.
Title:	Up-regulation of vitamin D3 up-regulated protein 1 gene in response to 5-fluorouracil in colon carcinoma SW620.
Author:	Takahashi, Yasuo\|Nagata, Toshihito\|Ishii, Yukimoto\|Ikarashi, Masahito\|Ishikawa, Koichi\|Asai, Satoshi
PMID:	11748459

7.
Journal:	Cancer Res. 2002 Sep 1;62(17):5089-95.
Title:	The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis.
Author:	Welsh, Sarah J\|Bellamy, William T\|Briehl, Margaret M\|Powis, Garth
PMID:	12208766

8.
Journal:	Am J Physiol Gastrointest Liver Physiol. 2002 Dec;283(6):G1352-9.
Title:	Glutathione and thioredoxin redox during differentiation in human colon epithelial (Caco-2) cells.
Author:	Nkabyo, Yvonne S\|Ziegler, Thomas R\|Gu, Li H\|Watson, Walter H\|Jones, Dean P
PMID:	12433666

9.
Journal:	Lab Invest. 2003 Sep;83(9):1321-31.
Title:	Thioredoxin reductase 1 expression in colon cancer: discrepancy between in vitro and in vivo findings.
Author:	Lechner, Sandra\|Muller-Ladner, Ulf\|Neumann, Elena\|Spottl, Tanja\|Schlottmann, Klaus\|Ruschoff, Josef\|Scholmerich, Jurgen\|Kullmann, Frank
PMID:	13679440

10.
Journal:	Anticancer Res. 2003 May-Jun;23(3B):2425-33.
Title:	The thioredoxin-thioredoxin reductase system: over-expression in human cancer.
Author:	Lincoln, David T\|Ali Emadi, Eman M\|Tonissen, Kathryn F\|Clarke, Frank M
PMID:	12894524

11.
Journal:	Mol Cancer Ther. 2003 Mar;2(3):235-43.
Title:	The thioredoxin redox inhibitors 1-methylpropyl 2-imidazolyl disulfide and pleurotin inhibit hypoxia-induced factor 1alpha and vascular endothelial growth factor formation.
Author:	Welsh, Sarah J\|Williams, Ryan R\|Birmingham, Anne\|Newman, David J\|Kirkpatrick, D Lynn\|Powis, Garth
PMID:	12657718

12.
Journal:	Di Yi Jun Yi Da Xue Xue Bao. 2005 Oct;25(10):1221-4.
Title:	[PCR amplification, cloning and protein expression of interferon-inducible transmembrane protein-1 gene].
Author:	Liu, Yu-hu\|Zhong, Dong\|Liu, Juan\|Zhang, Zhen-shu\|Chen, Cun-long\|Wu, Jin-bao\|Xiao, Bing\|Guo, Wen-ying
PMID:	16234093

13.
Journal:	Anticancer Drugs. 2006 Jun;17(5):539-44.
Title:	Thioredoxin reductase and cancer cell growth inhibition by organogold(III) compounds.
Author:	Engman, Lars\|McNaughton, Michael\|Gajewska, Malgorzata\|Kumar, Sangit\|Birmingham, Anne\|Powis, Garth
PMID:	16702810

14.
Journal:	Br J Pharmacol. 2007 Aug;151(8):1167-75.
Title:	A cellular and molecular investigation of the action of PMX464, a putative thioredoxin inhibitor, in normal and colorectal cancer cell lines.
Author:	Mukherjee, A\|Huber, K\|Evans, H\|Lakhani, N\|Martin, S
PMID:	17572693

15.
Journal:	Hum Pathol. 2008 Feb;39(2):201-8.
Title:	Increased expression of thioredoxin-1, vascular endothelial growth factor, and redox factor-1 is associated with poor prognosis in patients with liver metastasis from colorectal cancer.
Author:	Noike, Terumasa\|Miwa, Shiro\|Soeda, Junpei\|Kobayashi, Akira\|Miyagawa, Shin-ichi
PMID:	17949784

16.
Journal:	Bioorg Med Chem Lett. 2008 Jun 15;18(12):3526-31.
Title:	Cycloalkyl-substituted aryl chloroethylureas inhibiting cell cycle progression in G0/G1 phase and thioredoxin-1 nuclear translocation.
Author:	Fortin, Jessica S\|Cote, Marie-France\|Lacroix, Jacques\|Patenaude, Alexandre\|Petitclerc, Eric\|C-Gaudreault, Rene
PMID:	18502639

17.
Journal:	Cancer Res. 2008 Oct 15;68(20):8269-77.
Title:	The thioredoxin system mediates redox-induced cell death in human colon cancer cells: implications for the mechanism of action of anticancer agents.
Author:	Sun, Yu\|Rigas, Basil
PMID:	18922898

18.
Journal:	Cancer Epidemiol. 2009 Oct;33(3-4):281-7.
Title:	Preferential overexpression of glutaredoxin3 in human colon and lung carcinoma.
Author:	Cha, Mee-Kyung\|Kim, Il-Han
PMID:	19797004

19.
Journal:	Dis Colon Rectum. 2010 Dec;53(12):1624-31.
Title:	Is local excision after complete pathological response to neoadjuvant chemoradiation for rectal cancer an acceptable treatment option?
Author:	Kundel, Yulia\|Brenner, Ronen\|Purim, Ofer\|Peled, Nir\|Idelevich, Efraim\|Fenig, Eyal\|Sulkes, Aaron\|Brenner, Baruch
PMID:	21178856

20.
Journal:	Rev Prat. 2010 Oct 20;60(8):1089-93.
Title:	[Operable colon cancer: initial strategy].
Author:	Andre, Thierry\|Tuvignon, Noshine\|Taieb, Julien\|Vaillant, Jean-Christophe\|Hannoun, Laurent\|de Gramont, Aimery
PMID:	21197740

21.
Journal:	Invest New Drugs. 2012 Aug;30(4):1591-6.
Title:	A phase I trial of PX-12, a small-molecule inhibitor of thioredoxin-1, administered as a 72-hour infusion every 21 days in patients with advanced cancers refractory to standard therapy.
Author:	Ramanathan, Ramesh K\|Stephenson, Joe J\|Weiss, Glen J\|Pestano, Linda A\|Lowe, Ann\|Hiscox, Alton\|Leos, Rafael A\|Martin, Julie C\|Kirkpatrick, Lynn\|Richards, Donald A
PMID:	21863237

22.
Journal:	Biochem Cell Biol. 2012 Apr;90(2):173-8.
Title:	Changes in the levels of thioredoxin and indoleamine-2,3-dioxygenase activity in plasma of patients with colorectal cancer treated with chemotherapy.
Author:	Cavia-Saiz, Monica\|Muniz, Pilar\|De Santiago, Reyes\|Herreros-Villanueva, Marta\|Garcia-Giron, Carlos\|Lopez, Ana Sofia\|Coma-Del Corral, Maria Jesus
PMID:	22257103

23.
Journal:	Biomed Chromatogr. 2013 Apr;27(4):440-50.
Title:	Comprehensive fluorogenic derivatization-liquid chromatography/tandem mass spectrometry proteomic analysis of colorectal cancer cell to identify biomarker candidate.
Author:	Koshiyama, Akiyo\|Ichibangase, Tomoko\|Imai, Kazuhiro
PMID:	22991145

24.
Journal:	Antioxid Redox Signal. 2013 Sep 20;19(9):899-911.
Title:	Thioredoxin-like protein 2 is overexpressed in colon cancer and promotes cancer cell metastasis by interaction with ran.
Author:	Lu, Yuanyuan\|Zhao, Xiaodi\|Li, Kai\|Luo, Guanhong\|Nie, Yongzhan\|Shi, Yongquan\|Zhou, Yi\|Ren, Gui\|Feng, Bin\|Liu, Zhenxiong\|Pan, Yan\|Li, Ting\|Guo, Xuegang\|Wu, Kaichun\|Miranda-Vizuete, Antonio\|Wang, Xin\|Fan, Daiming
PMID:	23311631

25.
Journal:	Expert Opin Ther Targets. 2013 Nov;17(11):1369-79.
Title:	Type 3 deiodinase and solid tumors: an intriguing pair.
Author:	Dentice, Monica\|Antonini, Dario\|Salvatore, Domenico
PMID:	23991650

26.
Journal:	Int J Immunopathol Pharmacol. 2014 Apr-Jun;27(2):169-83.
Title:	Expression of thioredoxins and glutaredoxins in human hepatocellular carcinoma: correlation to cell proliferation, tumor size and metabolic syndrome.
Author:	Mollbrink, A\|Jawad, R\|Vlamis-Gardikas, A\|Edenvik, P\|Isaksson, B\|Danielsson, O\|Stal, P\|Fernandes, A P
PMID:	25004829

27.
Journal:	J Agric Food Chem. 2014 Mar 19;62(11):2353-63.
Title:	Secretome profiling reveals the signaling molecules of apoptotic HCT116 cells induced by the dietary polyacetylene gymnasterkoreayne B.
Author:	Kang, Kyungsu\|Song, Dae-Geun\|Lee, Eun Ha\|Lee, Kyung-Mi\|Park, Young Gyun\|Jung, Sang Hoon\|Pan, Cheol-Ho\|Nho, Chu Won
PMID:	24571669

28.
Journal:	Biochim Biophys Acta. 2014 Mar;1840(3):1135-44.
Title:	Powerful tumor cell growth-inhibiting activity of a synthetic derivative of atractyligenin: involvement of PI3K/Akt pathway and thioredoxin system.
Author:	Cotugno, Roberta\|Gallotta, Dario\|Piaz, Fabrizio Dal\|Apicella, Ivana\|De Falco, Sandro\|Rosselli, Sergio\|Bruno, Maurizio\|Belisario, Maria Antonietta
PMID:	24321480

29.
Journal:	Oncol Rep. 2015 Feb;33(2):967-73.
Title:	Thioredoxin-1 inhibitor, 1-methylpropyl 2-imidazolyl disulfide, inhibits the growth, migration and invasion of colorectal cancer cell lines.
Author:	Wang, Fule\|Lin, Feiyan\|Zhang, Peili\|Ni, Wuhua\|Bi, Laixi\|Wu, Jianbo\|Jiang, Lei
PMID:	25483731

30.
Journal:	Cancer Lett. 2015 Jul 28;363(2):119-26.
Title:	Thioredoxin-like protein 2b facilitates colon cancer cell proliferation and inhibits apoptosis via NF-kappaB pathway.
Author:	Lu, Yuanyuan\|Zhao, Xiaodi\|Luo, Guanhong\|Shen, Gaofei\|Li, Kai\|Ren, Gui\|Pan, Yan\|Wang, Xin\|Fan, Daiming
PMID:	25555669

31.
Journal:	Redox Biol. 2015 Aug;5:319-27.
Title:	Disruption of thioredoxin metabolism enhances the toxicity of transforming growth factor beta-activated kinase 1 (TAK1) inhibition in KRAS-mutated colon cancer cells.
Author:	Hrabe, Jennifer E\|O'Leary, Brianne R\|Fath, Melissa A\|Rodman, Samuel N\|Button, Anna M\|Domann, Frederick E\|Spitz, Douglas R\|Mezhir, James J
PMID:	26114584

32.
Journal:	Oncotarget. 2016 Mar 1;7(9):10578-93.
Title:	Heterogenous ribonucleoprotein A18 (hnRNP A18) promotes tumor growth by increasing protein translation of selected transcripts in cancer cells.
Author:	Chang, Elizabeth T\|Parekh, Palak R\|Yang, Qingyuan\|Nguyen, Duc M\|Carrier, France
PMID:	26824423

33.
Journal:	Oncotarget. 2016 Sep 20;7(38):62559-62571.
Title:	Mechanism of suppressors of cytokine signaling 1 inhibition of epithelial-mesenchymal transition signaling through ROS regulation in colon cancer cells: suppression of Src leading to thioredoxin up-regulation.
Author:	Jung, Sung-Hoon\|Kim, Su-Min\|Lee, Choong-Eun
PMID:	27613835

34.
Journal:	J Biol Chem. 2017 Jun 2;292(22):9136-9149.
Title:	Physical interaction between human ribonucleotide reductase large subunit and thioredoxin increases colorectal cancer malignancy.
Author:	Lou, Meng\|Liu, Qian\|Ren, Guoping\|Zeng, Jiling\|Xiang, Xueping\|Ding, Yongfeng\|Lin, Qinghui\|Zhong, Tingting\|Liu, Xia\|Zhu, Lijun\|Qi, Hongyan\|Shen, Jing\|Li, Haoran\|Shao, Jimin
PMID:	28411237

35.
Journal:	J Cell Mol Med. 2018 Apr;22(4):2430-2441.
Title:	Interplay between Trx-1 and S100P promotes colorectal cancer cell epithelial-mesenchymal transition by up-regulating S100A4 through AKT activation.
Author:	Zuo, Zhigui\|Zhang, Peili\|Lin, Feiyan\|Shang, Wenjing\|Bi, Ruichun\|Lu, Fengying\|Wu, Jianbo\|Jiang, Lei
PMID:	29383839

36.
Journal:	Oncol Lett. 2018 Feb;15(2):2364-2372.
Title:	Peroxiredoxin 1 expression in active ulcerative colitis mucosa identified by proteome analysis and involvement of thioredoxin based on immunohistochemistry.
Author:	Horie, Kayo\|Mikami, Tetuo\|Yoshida, Tsutomu\|Sato, Yuichi\|Okayasu, Isao
PMID:	29434945